Foresite Capital portfolio
50 tracked investments, 13 on the map, $6.4B raised across the mapped portfolio.
Foresite Capital50 investments · 13 on the map · $6.4B raised
Intellia TherapeuticsSeries B
Xaira Therapeutics
Invivyd
Element BiosciencesSeries D
insitroSeries C
CG OncologySeries F
Keros TherapeuticsSeries C
DELFI DiagnosticsSeries B
Seaport Therapeutics
Sollis HealthSeries B
MyOmeSeries B
REGENXBIOSeries D
Intarcia Therapeutics
Also in the portfolio
- Midi Health
- Tempest Therapeutics
- 23andMe
- Crossover Health
- Avenzo Therapeutics
- Thyme Care
- Latigo Biotherapeutics
- Quantum SI
- DNAnexus
- Tasso
- Folx Health
- Genomics
- Mirvie
- Affinivax
- Replimune Group
- Pleno
- Abcuro
- Genapsys
- Mammoth Biosciences
- Aetion
- ALX Oncology
- Venatorx Pharmaceuticals
- Adaptimmune
- Theseus Pharmaceuticals
- ImmPACT Bio
- evonetix
- Cullinan Therapeutics
- Pharvaris
- Generation Bio
- CASI Pharmaceuticals
- Jounce Therapeutics
- Aimmune Therapeutics
- Aduro BioTech
- Turning Point Therapeutics
- Sequenta
- Sestina Bio
Investors similar to Foresite Capital
OrbiMed177 investments · 137 on the map · $9.6B raised
T. Rowe Price153 investments · 69 on the map · $16B raised
Fidelity223 investments · 153 on the map · $17.4B raised
Venrock176 investments · 119 on the map · $2.4B raised
Google Ventures353 investments · 250 on the map · $28.1B raised
RA Capital Management150 investments · 92 on the map · $6.7B raised